Alex M. DePaoli

Corporate Officer/Principal en Sansum Diabetes Research Institute .

Health Technology

Commercial Services

Perfil

Alex M.
DePaoli is currently a Senior Endocrinologist at Sansum Diabetes Research Institute.
Previously, he held positions as Director-Global Development at Amgen, Inc., Chief Medical Officer at InteKrin Therapeutics, Inc., and Chief Medical Officer & Senior Vice President at NGM Biopharmaceuticals, Inc. (2010-2019).

Cargos activos de Alex M. DePaoli

Empresas	Cargo	Inicio
Sansum Diabetes Research Institute Sansum Diabetes Research Institute Miscellaneous Commercial ServicesCommercial Services Sansum Diabetes Research Institute is an American company that is dedicated to improving the lives of people affected by diabetes through research, education, and care.	Corporate Officer/Principal	-

Todos los cargos activos de Alex M. DePaoli

Antiguos cargos conocidos de Alex M. DePaoli.

Empresas	Cargo	Fin
AMGEN INC.	Corporate Officer/Principal	-
NGM BIOPHARMACEUTICALS, INC.	Chief Tech/Sci/R&D Officer	20/03/2019
InteKrin Therapeutics, Inc. InteKrin Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology InteKrin Therapeutics, Inc. develops and commercializes therapeutics for metabolic and immune disorders. It develops therapeutics for diabetes, insulin resistance and multiple sclerosis. The company was founded by Dennis M. Lanfear and Christos S. Mantzoros in 2005 and is headquartered in Palo Alto, CA.	Chief Tech/Sci/R&D Officer	-

Ver el detalle de la experiencia de Alex M. DePaoli.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas